Atenolol: pharmacokinetic/dynamic aspects of comparative developmental toxicity.
about
Infrared laser-assisted desorption electrospray ionization mass spectrometry.Atenolol exposure and risk for development of adverse metabolic effects: a pilot studyAtenolol Renal Secretion Is Mediated by Human Organic Cation Transporter 2 and Multidrug and Toxin Extrusion Proteins.Apple juice greatly reduces systemic exposure to atenolol
P2860
Atenolol: pharmacokinetic/dynamic aspects of comparative developmental toxicity.
description
2002 nî lūn-bûn
@nan
2002 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Atenolol: pharmacokinetic/dynamic aspects of comparative developmental toxicity.
@ast
Atenolol: pharmacokinetic/dynamic aspects of comparative developmental toxicity.
@en
Atenolol: pharmacokinetic/dynamic aspects of comparative developmental toxicity.
@nl
type
label
Atenolol: pharmacokinetic/dynamic aspects of comparative developmental toxicity.
@ast
Atenolol: pharmacokinetic/dynamic aspects of comparative developmental toxicity.
@en
Atenolol: pharmacokinetic/dynamic aspects of comparative developmental toxicity.
@nl
prefLabel
Atenolol: pharmacokinetic/dynamic aspects of comparative developmental toxicity.
@ast
Atenolol: pharmacokinetic/dynamic aspects of comparative developmental toxicity.
@en
Atenolol: pharmacokinetic/dynamic aspects of comparative developmental toxicity.
@nl
P1476
Atenolol: pharmacokinetic/dynamic aspects of comparative developmental toxicity.
@en
P2093
Carole A Kimmel
Sonia A Tabacova
P356
10.1016/S0890-6238(01)00193-9
P577
2002-01-01T00:00:00Z